Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders
CM Díaz-Caneja, Matthew W. State, RJ Hagerman, et al.
European Neuropsychopharmacology (2021) Vol. 48, pp. 49-88
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Genomics, convergent neuroscience and progress in understanding autism spectrum disorder
Helen Rankin Willsey, A. Jeremy Willsey, Belinda Wang, et al.
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 6, pp. 323-341
Open Access | Times Cited: 140
Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications
Chen-Chen Jiang, Lishan Lin, Sen Long, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 130
Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy
Xuan Wang, Binquan Wang, Chunyan Wu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1819-1819
Open Access | Times Cited: 104
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Spyridon Siafis, Remzi Oğulcan Çıray, Hui Wu, et al.
Molecular Autism (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 71
Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders
Rania Awad, Avi Avital, Alejandro Sosnik
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1866-1886
Open Access | Times Cited: 65
Novel treatments in autism spectrum disorder
Danielle Baribeau, Jacob Vorstman, Evdokia Anagnostou
Current Opinion in Psychiatry (2022) Vol. 35, Iss. 2, pp. 101-110
Closed Access | Times Cited: 38
Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy
Eleonora Aronica, Nicola Specchio, Mark J. Luinenburg, et al.
Brain (2023) Vol. 146, Iss. 7, pp. 2694-2710
Open Access | Times Cited: 37
TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model
Qiang Shao, Che-Wei Chang, Zhiyong Li, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 642
Open Access | Times Cited: 31
Twenty years of discoveries emerging from mouse models of autism
Jacqueline N. Crawley
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105053-105053
Open Access | Times Cited: 19
Sleep Abnormalities in the Synaptopathies—SYNGAP1-Related Intellectual Disability and Phelan–McDermid Syndrome
Constance Smith‐Hicks, Damien Wright, Aisling Kenny, et al.
Brain Sciences (2021) Vol. 11, Iss. 9, pp. 1229-1229
Open Access | Times Cited: 36
Neurodevelopmental disorders, immunity, and cancer are connected
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
iScience (2022) Vol. 25, Iss. 6, pp. 104492-104492
Open Access | Times Cited: 25
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society
Lisi Flores Aguilar, Eric D. Hamlett, Paula Araya, et al.
NeuroMolecular Medicine (2025) Vol. 27, Iss. 1
Open Access
Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides
Heba M. Mansour, Aiman S. El‐Khatib
European Journal of Pharmacology (2025), pp. 177529-177529
Closed Access
Epigenetics and Neuroinflammation Associated With Neurodevelopmental Disorders: A Microglial Perspective
Munekazu Komada, Yuhei Nishimura
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 18
Recent Developments in Autism Genetic Research: A Scientometric Review from 2018 to 2022
Mengyu Lim, Alessandro Carollo, Dagmara Dimitriou, et al.
Genes (2022) Vol. 13, Iss. 9, pp. 1646-1646
Open Access | Times Cited: 17
Improving clinical trial readiness to accelerate development of new therapeutics for Rett syndrome
Helen Leonard, Wendy Gold, Rodney C. Samaco, et al.
Orphanet Journal of Rare Diseases (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Embryonic mercury exposure in zebrafish: Alteration of metabolites and gene expression, related to visual and behavioral impairments
Noraini Abu Bakar, Wan Norhamidah Wan Ibrahim, Abdul Rahman Zulkiflli, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 256, pp. 114862-114862
Open Access | Times Cited: 9
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications
Samuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105149-105149
Open Access | Times Cited: 8
Neurodevelopmental disorders as a risk factor for temporomandibular disorder: evidence from Mendelian randomization studies
Xueqiang Wu, Zefang Li, Yiping Cui, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 2
European Autism GEnomics Registry (EAGER): protocol for a multicentre cohort study and registry
Madeleine Bloomfield, Alexandra Lautarescu, Síofra Heraty, et al.
BMJ Open (2024) Vol. 14, Iss. 6, pp. e080746-e080746
Open Access | Times Cited: 2
Points to consider when initiating clinical investigations in autistic paediatric populations–A White Paper
Lindsay Ham, Hannah Staunton, Jan M. Schulz, et al.
European Neuropsychopharmacology (2024) Vol. 86, pp. 35-42
Open Access | Times Cited: 2
Widespread Gene Editing in the Brain via In Utero Delivery of mRNA Using Acid-Degradable Lipid Nanoparticles
Kewa Gao, Hesong Han, Matileen Grace Cranick, et al.
ACS Nano (2024) Vol. 18, Iss. 44, pp. 30293-30306
Open Access | Times Cited: 2
The pediatric psychopharmacology of autism spectrum disorder: A systematic review part II: The future
Antonio M. Persico, Lisa Asta, Fethia Chehbani, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024), pp. 111176-111176
Closed Access | Times Cited: 2
Targeted Treatments for Fragile X Syndrome
Devon Johnson, Courtney Clark, Randi J. Hagerman
Advances in neurobiology (2023), pp. 225-253
Closed Access | Times Cited: 5
Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study
James Robert Brašić, Jack Alexander Goodman, Ayon Nandi, et al.
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 314-314
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top